CS130692A3 - Medicament for dementia treatment - Google Patents

Medicament for dementia treatment

Info

Publication number: CS130692A3
Authority: CS; Czechoslovakia
Prior art keywords: dementia; disturbances; present; improving; medicament
Prior art date: 1991-05-02

Application number

CS921306A

Other languages

English (en)

Inventor

Eiichi Otomo

Yoshiyuki Takasu

Tadashi Shiotani

Kazuo Hasegawa

Akira Honma

Original Assignee

Daiichi Seiyaku Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-05-02

Filing date

1992-04-29

Publication date

1992-11-18

1992-04-29 Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co

1992-11-18 Publication of CS130692A3 publication Critical patent/CS130692A3/cs

1996-07-17 Publication of CZ281170B6 publication Critical patent/CZ281170B6/cs

Links

206010012289 Dementia Diseases 0.000 title abstract 3
239000003814 drug Substances 0.000 title abstract 2
208000024891 symptom Diseases 0.000 abstract 2
206010000117 Abnormal behaviour Diseases 0.000 abstract 1
208000024827 Alzheimer disease Diseases 0.000 abstract 1
239000004480 active ingredient Substances 0.000 abstract 1
208000013677 cerebrovascular dementia Diseases 0.000 abstract 1
239000003795 chemical substances by application Substances 0.000 abstract 1
230000007423 decrease Effects 0.000 abstract 1
230000003247 decreasing effect Effects 0.000 abstract 1
229940079593 drug Drugs 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
230000004970 emotional disturbance Effects 0.000 abstract 1
230000006870 function Effects 0.000 abstract 1
230000003340 mental effect Effects 0.000 abstract 1
230000008450 motivation Effects 0.000 abstract 1
NGHTXZCKLWZPGK-UHFFFAOYSA-N nefiracetam Chemical compound CC1=CC=CC(C)=C1NC(=O)CN1C(=O)CCC1 NGHTXZCKLWZPGK-UHFFFAOYSA-N 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Neurology (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Engineering & Computer Science (AREA)
Neurosurgery (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Pyrrole Compounds (AREA)
Materials For Medical Uses (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Steroid Compounds (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Plural Heterocyclic Compounds (AREA)
Medicinal Preparation (AREA)

CS921306A 1991-05-02 1992-04-29 Léčivo pro léčení demence CZ281170B6 (cs)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP22981891		1991-05-02
JP22981991		1991-05-02

Publications (2)

Publication Number	Publication Date
CS130692A3 true CS130692A3 (en)	1992-11-18
CZ281170B6 CZ281170B6 (cs)	1996-07-17

Family

ID=26529012

Country Status (21)

Country	Link
US (1)	US5886023A (cs)
EP (1)	EP0515866B1 (cs)
KR (1)	KR100310590B1 (cs)
AT (1)	ATE203402T1 (cs)
AU (2)	AU1595492A (cs)
CA (1)	CA2067614C (cs)
CZ (1)	CZ281170B6 (cs)
DE (1)	DE69231955T2 (cs)
DK (1)	DK0515866T3 (cs)
ES (1)	ES2160097T3 (cs)
GR (1)	GR3036970T3 (cs)
HU (1)	HU224689B1 (cs)
IE (1)	IE921377A1 (cs)
IL (1)	IL101738A (cs)
MX (1)	MX9202058A (cs)
NO (1)	NO312813B1 (cs)
PT (1)	PT515866E (cs)
RU (1)	RU2070042C1 (cs)
SG (1)	SG49650A1 (cs)
SK (1)	SK279285B6 (cs)
TW (1)	TW199096B (cs)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR20000048847A (ko) *	1996-10-01	2000-07-25	스즈키 다다시	미토콘드리아 막 안정화제
DE69823851D1 (de)	1997-07-15	2004-06-17	Daiichi Seiyaku Co	Nefiracetam zur prophylaxe und behandlung von propofol verursachtem gedächtnisschwund
IT1312107B1 (it) *	1999-05-14	2002-04-04	Umberto Cornelli	Glicosaminoglicani aventi peso molecolare medio di 2400 d atti altrattamento della demenza senile
US20040077709A1 (en) *	1999-05-31	2004-04-22	Daiichi Pharmaceutical Co., Ltd.	Neuronal death inhibitors
HK1048268A1 (zh) *	1999-05-31	2003-03-28	第一制药株式会社	神经元死亡抑制剂
US6376489B1 (en) *	1999-12-23	2002-04-23	Icos Corporation	Cyclic AMP-specific phosphodiesterase inhibitors
GB0004297D0 (en) *	2000-02-23	2000-04-12	Ucb Sa	2-oxo-1 pyrrolidine derivatives process for preparing them and their uses
US6423739B1 (en)	2000-02-23	2002-07-23	Daiichi Pharmaceutical Co., Ltd.	Method for aiding cerebral recovery following neurodegeneration
US6348489B1 (en) *	2000-04-11	2002-02-19	Daiichi Pharmaceutical Co., Ltd.	Method of treating traumatic brain injury and other neuronal disorders
EP1356812B1 (en) *	2000-12-28	2009-05-13	Hamilton Pharmaceuticals, Inc.	Medicines for treatment and prevention of neurogenic pain
JP2005501108A (ja) *	2001-08-22	2005-01-13	第一製薬株式会社	神経変性治療におけるネフィラセタムの使用
US20060241144A1 (en) *	2005-04-20	2006-10-26	Albert Cha	Method for treating apathy syndrome
US7972633B2 (en) *	2007-02-07	2011-07-05	Applied Cognitive Sciences, LLC	Nutritional supplements for healthy memory and mental function
RU2327480C1 (ru) *	2007-05-23	2008-06-27	Виктор Иванович Рощин	Активный ингредиент лекарственного средства, лекарственное средство, фармацевтическая композиция и способ лечения больных с дементным синдромом
ES2865504T3 (es) *	2008-10-16	2021-10-15	Univ Johns Hopkins	Procedimientos y composiciones para la mejora de la función cognitiva
AU2011215870B2 (en) *	2010-02-09	2016-01-28	The Johns Hopkins University	Methods and compositions for improving cognitive function
US20140206667A1 (en)	2012-11-14	2014-07-24	Michela Gallagher	Methods and compositions for treating schizophrenia
WO2014144663A1 (en)	2013-03-15	2014-09-18	The Johns Hopkins University	Methods and compositions for improving cognitive function
JP6433482B2 (ja)	2013-03-15	2018-12-05	エージンバイオ，インコーポレイテッド	認知機能を改善するための方法および組成物
WO2016191288A1 (en)	2015-05-22	2016-12-01	Agenebio, Inc.	Extended release pharmaceutical compositions of levetiracetam

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE864269A (fr) *	1977-03-03	1978-06-16	Parke Davis & Co	Nouveaux n-(aminoalkyl substitue)-2-oxo-1-pyrrolidine-acetamides et procedes pour les produire
IT1141287B (it) *	1979-06-13	1986-10-01	Nattermann A & Cie	Ammidi di acidi pirrolidin-(2)-on-(1)-ilalchil-carbossilici,procedimento per la loro preparazione e prodotti medicinali che le contengono
US4385053A (en) *	1981-03-11	1983-05-24	Barry Reisberg	Treatment for human memory impairment associated with aging
JPH0699307B2 (ja) *	1987-08-20	1994-12-07	キッセイ薬品工業株式会社	抗痴呆剤
IT1231477B (it) *	1989-07-12	1991-12-07	Sigma Tau Ind Farmaceuti	(pirrolidin-2-one-1-il) acetammidi quali attivatori dei processi di apprendimento e della memoria e composizioni farmaceutiche comprendenti tali composti

1992
- 1992-04-29 SK SK1306-92A patent/SK279285B6/sk unknown
- 1992-04-29 CA CA002067614A patent/CA2067614C/en not_active Expired - Lifetime
- 1992-04-29 CZ CS921306A patent/CZ281170B6/cs not_active IP Right Cessation
- 1992-04-30 DE DE69231955T patent/DE69231955T2/de not_active Expired - Lifetime
- 1992-04-30 HU HU9201477A patent/HU224689B1/hu not_active IP Right Cessation
- 1992-04-30 RU SU5011760/14A patent/RU2070042C1/ru not_active IP Right Cessation
- 1992-04-30 ES ES92107421T patent/ES2160097T3/es not_active Expired - Lifetime
- 1992-04-30 SG SG1996002798A patent/SG49650A1/en unknown
- 1992-04-30 NO NO19921724A patent/NO312813B1/no unknown
- 1992-04-30 PT PT92107421T patent/PT515866E/pt unknown
- 1992-04-30 IL IL10173892A patent/IL101738A/en active IP Right Grant
- 1992-04-30 EP EP92107421A patent/EP0515866B1/en not_active Expired - Lifetime
- 1992-04-30 AT AT92107421T patent/ATE203402T1/de not_active IP Right Cessation
- 1992-04-30 MX MX9202058A patent/MX9202058A/es not_active IP Right Cessation
- 1992-04-30 DK DK92107421T patent/DK0515866T3/da active
- 1992-05-01 AU AU15954/92A patent/AU1595492A/en not_active Abandoned
- 1992-05-01 TW TW081103420A patent/TW199096B/zh active
- 1992-05-01 KR KR1019920007433A patent/KR100310590B1/ko not_active Expired - Fee Related
- 1992-07-01 IE IE137792A patent/IE921377A1/en not_active IP Right Cessation
1995
- 1995-05-22 US US08/447,054 patent/US5886023A/en not_active Expired - Fee Related
- 1995-11-08 AU AU37745/95A patent/AU697936B2/en not_active Ceased
2001
- 2001-10-22 GR GR20010401840T patent/GR3036970T3/el not_active IP Right Cessation

Also Published As

Publication number	Publication date
HUT62790A (en)	1993-06-28
KR920021143A (ko)	1992-12-18
DK0515866T3 (da)	2001-09-24
ATE203402T1 (de)	2001-08-15
AU1595492A (en)	1992-11-05
MX9202058A (es)	1993-03-01
IE921377A1 (en)	1992-11-04
NO921724L (no)	1992-11-03
DE69231955T2 (de)	2002-04-04
RU2070042C1 (ru)	1996-12-10
EP0515866A1 (en)	1992-12-02
DE69231955D1 (de)	2001-08-30
NO312813B1 (no)	2002-07-08
HU9201477D0 (en)	1992-07-28
ES2160097T3 (es)	2001-11-01
TW199096B (cs)	1993-02-01
CZ281170B6 (cs)	1996-07-17
IL101738A (en)	1999-01-26
SK279285B6 (sk)	1998-09-09
KR100310590B1 (ko)	2001-12-28
HK1002153A1 (en)	1998-07-31
CA2067614A1 (en)	1992-11-03
US5886023A (en)	1999-03-23
IL101738A0 (en)	1992-12-30
PT515866E (pt)	2001-11-30
EP0515866B1 (en)	2001-07-25
GR3036970T3 (en)	2002-01-31
AU697936B2 (en)	1998-10-22
SG49650A1 (en)	1998-06-15
HU224689B1 (hu)	2005-12-28
NO921724D0 (no)	1992-04-30
CA2067614C (en)	2002-07-30
AU3774595A (en)	1996-03-07

Legal Events

Date	Code	Title	Description
2000-06-30	IF00	In force as of 2000-06-30 in czech republic
2009-01-21	MM4A	Patent lapsed due to non-payment of fee	Effective date: 20080429

Publication	Publication Date	Title
CS130692A3 (en)	1992-11-18	Medicament for dementia treatment
PT1040830E (pt)	2005-08-31	Medicamento para doencas neurodegenerativas
DE59109222D1 (de)	2001-11-22	Verwendung des Wirkstoffs Flupirtin zur Herstellung eines Arzneimittels zur Bekämpfung von Muskelverspannungen
DE4497905T1 (de)	1996-10-31	Pharmazeutische Zusammensetzung zur Prävention und Behandlung des Motion-Sickness-Syndroms
RU93032613A (ru)	1996-06-20	Фармацевтический препарат для лечения пациентов с пролонгированным временем коагуляции, способ лечения пациентов, применение epi ингибитора для получения фармацевтического препарата
ATE252389T1 (de)	2003-11-15	Ein arzneimittel zur behandlung von fettleibigkeit und verbesserung des lipidmetabolismus
ATE78696T1 (de)	1992-08-15	Arzneimittelzubereitung zur behandlung des immunmangels.
IL91047A (en)	1993-06-10	Zinc complexes for the treatment of free radical- induced diseases
RU94046141A (ru)	1996-09-27	Замещенные производные /арилалкоксибензил/ аминопропанамида, способы их получения, фармацевтическая композиция
NO302472B1 (no)	1998-03-09	Sulfonylureaforbindelse, farmasöytisk formulering og anvendelse derav
DE69024060D1 (de)	1996-01-18	Osteogenesis-stimulierende mittel.
NO179472C (no)	1996-10-16	Opplösning omfattende benzoxoniumklorid for behandling av kontaktlinser, og anvendelse derav til konservering av kontaktlinser og legemidler for öynene
GR3034161T3 (en)	2000-11-30	Pharmaceutical composition for preventing or treating.
DE68901172D1 (de)	1992-05-14	(-)-2-pyrazolinverbindung, deren optischen aufspaltung und therapeutisches agens zur behandlung von zerebralen gefaesskrankheiten, diese verbindung als aktives ingredient enthaltend.
DK0826373T3 (da)	2003-09-29	Forebyggende middel mod postoperativ astigmatisme
ES2085665T3 (es)	1996-06-01	Agente neuroprotector.
DE68906437D1 (de)	1993-06-17	L-pyroglutamyl-l-cystein-dipeptid mit hoher anti-cataractogener wirkung und dies enthaltende pharmazeutische zusammensetzungen.
CA2154485A1 (en)	1994-08-04	Pharmaceutical composition containing 5-morpholinomethyl-3-(4-chlorobenzylideneamine)-2-oxazolidinone and its use for the treatment of cns disorders
UA30143A (uk)	2000-11-15	Лікувальний препарат для профілактики та лікування інфекційних та запальних захворювань
IL93728A0 (en)	1990-12-23	Antiviral pharmaceutical compositions containing cyclic amines